TIS 0.00% 0.0¢ tissue therapies limited

Interesting article. I point to the following paragraph. He says...

  1. 427 Posts.
    lightbulb Created with Sketch. 7
    Interesting article. I point to the following paragraph.

    He says FDA approval is more expensive and time consuming than endorsement from Australia’s Therapeutic Goods Administration, which, while no picnic, helps support European approval.

    I think we have all wondered from time to time why this course of action was not followed for the Vitrogro.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.